Bronchoscopic Lung Tumor Ablation Using Conductive Hypertonic Saline

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for bronchoscopic ablation of lung tumors face challenges due to high tissue impedance, air volume, and the difficulty of navigating ablation electrodes to peripheral tumors, limiting the effectiveness of radiofrequency (RF) energy delivery.

Innovation Solution

The use of conductive fluids like hypertonic saline to reduce tissue impedance, combined with RF ablation energy, and techniques to collapse lung tissue volume to enhance electrode-tissue contact, allowing for more efficient RF energy delivery through a system that includes a flow regulator and sensors for real-time control of energy and fluid delivery.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If percutaneous RF ablation with needle electrode is used, then immediate technical success rate is over 95%, but major complication rate is 8 to 12% and requires CT guidance

Engineering Contradiction:
Improveimmediate technical success rateVSAvoidmajor complication rate
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

A conductive fluid (such as saline solution) is introduced as an intermediary between the RF electrode and the lung tumor tissue. This fluid mediates the energy transfer by reducing electrical impedance at the interface, allowing more efficient RF energy delivery to the tumor while reducing the risk of complications such as pneumothorax and tissue damage

Inventive Principle:
Principle #24Intermediary (Mediator)

2Length of moving object

If bronchoscopic ablation is performed through working channel of bronchoscope, then access to peripheral tumors is enabled, but ablation electrode navigation difficulty increases and ablation volume is limited

Engineering Contradiction:
Improvereach to peripheral tumorsVSAvoidelectrode navigation difficulty
Core Design Contradiction:
Length of moving objectVSEase of operation

Solution Approach 1:

The ablation system is segmented into modular components: a navigable bronchoscope for access, a separate catheter for electrode delivery, and a deployable electrode array. This segmentation allows the bronchoscope to navigate to peripheral tumors while the electrode catheter can be independently positioned and deployed at the target site, reducing navigation complexity

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The ablation electrode catheter is nested within the bronchoscope's working channel during navigation. Once the bronchoscope reaches the peripheral tumor location, the nested catheter is deployed outward from the bronchoscope to position the electrode array at the tumor site, enabling access to distant locations while maintaining operational simplicity

Inventive Principle:
Principle #7Nested doll (Nesting)

3Reliability

If RF ablation is performed in lung tissue with air and blood perfusion, then treatment of lung tumors is achieved, but tissue impedance increases and cooling effect reduces ablation effectiveness

Engineering Contradiction:
Improveablation effectivenessVSAvoidtissue impedance
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

A conductive fluid is introduced as an intermediary substance between the RF electrode and the lung tissue. This fluid displaces air at the electrode-tissue interface, reducing electrical impedance and improving current flow into the tissue. The fluid also creates a more stable thermal environment by reducing evaporative cooling, thereby enhancing ablation effectiveness

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The electrical and thermal parameters of the treatment environment are changed by introducing conductive fluid. The fluid alters the electrical conductivity of the interface region, reducing impedance from high (air-filled) to low (fluid-filled). It also modifies thermal parameters by reducing evaporative heat loss and improving thermal coupling between electrode and tissue

Inventive Principle:
Principle #35Parameter changes

4Reliability

If microwave energy is used instead of RF, then air volume interference is reduced, but simplicity and efficiency of RF heating is lost

Engineering Contradiction:
Improveenergy delivery through airVSAvoidsystem complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

A conductive fluid is introduced as an intermediary that eliminates the need for microwave energy by providing a conductive pathway for RF energy. The fluid displaces air in the treatment zone, allowing standard RF systems to function effectively without requiring complex microwave generation and delivery equipment, thus maintaining system simplicity while achieving reliable energy delivery

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach improves the effectiveness of RF energy delivery, increasing the size of ablation zones and reducing complications, enabling more precise and efficient treatment of lung tumors, particularly those in harder-to-reach peripheral locations.

Implementation Method 1

delivering conductive fluid (e.g. HTS) into the airway through the endobronchial ablation catheter to reduce tissue impedance and increase the effective RF energy delivery electrode size

Methodology Applied
Scientific EffectElectrical impedance reduction: Conduction (electrical)

Implementation Method 2

Ablating the tumor with RF ablation energy using monopolar, multiple monopolar, bipolar, multi-polar and multiphasic RF configurations

Methodology Applied
Scientific EffectRadiofrequency heating: Joule Heating

Implementation Method 3

Collapsing, compressing, air-volume reducing or partially collapsing a portion of a lung comprising a tumor to ablate the tumor

Methodology Applied
Scientific EffectAir volume reduction: Compression

Data Source

PatentUS20240115310A1Systems, devices and methods for treating lung tumor
Publication Date: 2024.04.11 ZIDAN MEDICAL INC
  • US20240115310A1 patent drawing
  • US20240115310A1 patent drawing
  • US20240115310A1 patent drawing

AI summary

A method to treat a human patient including: advancing a catheter through a natural airway of the patient and positioning a distal portion of the catheter in the natural airway of a lung of the patient to a target region in the lung, injecting a conductive hypertonic saline solution having a concentration of at least 5% of sodium chloride by weight/volume from the distal portion of the catheter into the target region; delivering energy from the distal portion into the hypertonic saline solution in the target region, wherein the energy heats the hypertonic saline solution in the target region; ablating the target region with the heated conductive hypertonic saline solution, sensing electric impedance or electric conductivity of the target region during the delivery of the energy, and controlling the rate or a bolus of the hypertonic saline solution injected into the target region based on the electric impedance or the electric conductivity.